Back to News
Market Impact: 0.05
Here's Why Kiniksa Pharmaceuticals International, plc (KNSA) is a Strong Momentum Stock
Source: zacks.com
Analyst Insights
The article promotes Zacks Style Scores, a feature of the Zacks Premium research service, as a tool intended to help value, growth, and momentum investors identify stocks. It provides no performance figures or other market-moving information.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- We're cutting our Qnity price target but still loved the beat-and-raise quarter
- Defense stocks slide on fear Democrats will curb spending. One analyst say it's a buying opportunity
- Vistra plunges 13.5% as Texas election rattles AI power trade, KeyBanc downgrades
- Investors should sell this struggling software stock, Citi says
- 248 Ventures’ Bell on What Qualcomm’s 4Q Mean for Tech
- Arm's Results Are 'Perfectly Fine,' CFRA's Zino Says